Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding

The diagnosis of hereditary hemorrhagic telangiectasia (HHT) is based on the Curaçao criteria: epistaxis, telangiectases, arteriovenous malformations in internal organs, and family history. Genetically speaking, more than 90% of HHT patients show mutations in <i>ENG</i> or <i>ACVRL...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Virginia Albiñana, Angel M Cuesta, Isabel de Rojas-P, Eunate Gallardo-Vara, Lucía Recio-Poveda, Carmelo Bernabéu, Luisa María Botella
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2020-06-01
Series:Journal of Clinical Medicine
Assuntos:
HHT
ALK1
endoglin
raloxifene
bazedoxifene
tranexamic acid
Acceso en liña:https://www.mdpi.com/2077-0383/9/6/1766
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares